Zacks Research Issues Pessimistic Forecast for ACHC Earnings

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Investment analysts at Zacks Research lowered their FY2024 earnings estimates for Acadia Healthcare in a research note issued on Wednesday, November 13th. Zacks Research analyst Z. Masood now anticipates that the company will post earnings of $3.37 per share for the year, down from their previous estimate of $3.46. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. Zacks Research also issued estimates for Acadia Healthcare’s Q4 2024 earnings at $0.71 EPS, Q1 2025 earnings at $0.76 EPS, Q2 2025 earnings at $0.94 EPS, Q1 2026 earnings at $0.88 EPS, Q2 2026 earnings at $0.99 EPS, Q3 2026 earnings at $1.07 EPS and FY2026 earnings at $3.99 EPS.

Other research analysts have also recently issued reports about the stock. Barclays decreased their price objective on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a research report on Monday, September 30th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. StockNews.com upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Thursday, November 14th. KeyCorp assumed coverage on Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Finally, Royal Bank of Canada dropped their price target on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a research note on Monday. Five research analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $83.33.

Acadia Healthcare Price Performance

Shares of NASDAQ ACHC opened at $37.13 on Monday. The firm has a market capitalization of $3.45 billion, a P/E ratio of 12.17, a P/E/G ratio of 1.68 and a beta of 1.33. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The stock’s 50-day simple moving average is $57.27 and its two-hundred day simple moving average is $65.34. Acadia Healthcare has a twelve month low of $36.50 and a twelve month high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. The firm had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.91 earnings per share.

Hedge Funds Weigh In On Acadia Healthcare

A number of large investors have recently bought and sold shares of ACHC. Blue Trust Inc. grew its holdings in shares of Acadia Healthcare by 86.1% in the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after purchasing an additional 248 shares during the last quarter. GAMMA Investing LLC grew its holdings in Acadia Healthcare by 57.1% in the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after acquiring an additional 241 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of Acadia Healthcare in the second quarter valued at about $59,000. Covestor Ltd raised its stake in shares of Acadia Healthcare by 834.4% during the third quarter. Covestor Ltd now owns 1,140 shares of the company’s stock valued at $72,000 after acquiring an additional 1,018 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale purchased a new stake in shares of Acadia Healthcare during the third quarter worth about $86,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.